RILUZOLE vs RISANKIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RILUZOLE vs RISANKIZUMAB: Safety Overview
| Metric | RILUZOLE | RISANKIZUMAB |
|---|---|---|
| Total FAERS Reports | 1,437 | 2,642 |
| Deaths Reported | 342 | 41 |
| Death Rate | 23.8% | 1.6% |
| Hospitalizations | 264 | 439 |
| Average Patient Age | 63.5 yrs | 52.1 yrs |
| % Female Patients | 47.5% | 51.3% |
| FDA Approval Date | Aug 22, 2024 | N/A |
| Manufacturer | EDW PHARMA | AbbVie Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Discontinued | N/A |